glutamic acid has been researched along with vu 0155041 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calaza, KC; Guimarães-Souza, EM | 1 |
| Ebrahimi, Z; Kahvandi, N; Karimi, SA; Komaki, A; Naderishahab, M; Sarihi, A; Shahriari, E; Sharifi, M | 1 |
2 other study(ies) available for glutamic acid and vu 0155041
| Article | Year |
|---|---|
Selective activation of group III metabotropic glutamate receptor subtypes produces different patterns of γ-aminobutyric acid immunoreactivity and glutamate release in the retina.
Topics: Amacrine Cells; Anilides; Animals; Benzhydryl Compounds; Calcium; Chickens; Cyclohexanecarboxylic Acids; Dizocilpine Maleate; GABA Plasma Membrane Transport Proteins; GABAergic Neurons; gamma-Aminobutyric Acid; Glutamic Acid; Nipecotic Acids; Oximes; Phosphoserine; Quinoxalines; Receptors, Metabotropic Glutamate | 2012 |
VU0155041, a positive allosteric modulator of mGluR4, in the nucleus accumbens facilitates extinction and inhibits the reinstatement of morphine-induced conditioned place preference in male rats.
Topics: Animals; Extinction, Psychological; Glutamic Acid; Male; Morphine; Nucleus Accumbens; Rats; Rats, Wistar | 2023 |